background
surgic
filter
facepiec
respir
ffr
certifi
nation
institut
occup
safeti
health
niosh
respir
clear
food
drug
administr
fda
surgic
mask
often
use
protect
inhal
infecti
aerosol
splashesspray
bodi
fluid
health
care
facil
shortag
respir
expect
pandem
avail
surgic
ffr
potenti
increas
incorpor
fda
clearanc
requir
niosh
respir
approv
process
method
fluid
resist
nioshapprov
ffr
fdaclear
surgic
ffr
surgic
mask
test
use
astm
method
cmsec
veloc
compar
result
thirdparti
independ
laboratori
blood
penetr
differ
layer
filter
media
mask
also
analyz
visual
result
four
ffr
model
show
test
failur
veloc
penetr
result
obtain
niosh
laboratori
compar
thirdparti
independ
laboratori
number
respir
sampl
fail
test
increas
increas
test
veloc
result
indic
sever
nioshapprov
ffr
model
would
like
pass
fda
clearanc
requir
resist
synthet
blood
penetr
surgic
mask
sm
facemask
refer
food
drug
administr
fda
clear
surgic
laser
isol
dental
medic
procedur
mask
without
face
shield
sm
cover
user
nose
mouth
provid
physic
barrier
splashesspray
larg
droplet
bodi
fluid
sm
use
health
care
personnel
surgic
nonsurg
procedur
protect
patient
health
care
worker
splashesspray
blood
bodi
fluid
fda
clear
sm
base
manufacturersubmit
test
data
propos
claim
manufactur
submit
test
result
particl
filtrat
effici
bacteri
filtrat
effici
fluid
resist
differenti
pressur
flammabl
fda
clearanc
use
respir
certifi
nation
institut
occup
safeti
health
niosh
least
protect
filter
facepiec
respir
ffr
recommend
care
patient
diseas
tuberculosi
measl
aerosolgener
procedur
patient
certain
infecti
diseas
eg
season
influenza
novel
influenza
ebola
viru
diseas
niosh
test
certifi
perform
ffr
accord
requir
outlin
us
titl
code
feder
regul
cfr
part
ffr
primari
test
filtrat
effici
airflow
resist
need
ffr
sm
capabl
eg
fluid
resist
flammabl
initi
address
start
fda
introduct
surgic
respir
nioshapprov
ffr
clear
fda
fluid
resist
flammabl
surgic
ffr
offer
protect
ffr
sm
properti
surgic
ffr
prefer
use
health
care
personnel
protect
either
fluid
aerosol
may
need
current
fda
clear
small
percentag
total
number
nioshcertifi
ffr
model
surgic
respir
categori
use
surgic
ffr
surgic
nonsurg
environ
increas
outbreak
involv
known
suspect
respiratori
pathogen
exampl
scarciti
respir
spread
sever
acut
respiratori
syndrom
influenza
report
one
possibl
option
increas
avail
surgic
ffr
protect
inhal
hazard
would
expand
niosh
certif
ffr
model
includ
addit
protect
fluid
resist
flammabl
better
assess
option
niosh
publish
request
inform
feder
regist
docket
desir
incorpor
addit
requir
test
cfr
part
respir
approv
process
match
fda
clearanc
requir
surgic
respir
niosh
provid
data
docket
show
nonfda
clear
nioshapprov
respir
routin
use
health
care
sever
model
type
devic
includ
unit
state
strateg
nation
stockpil
use
public
health
emerg
pandem
niosh
solicit
data
perform
nonfda
clear
nioshapprov
respir
fluid
resist
splashesspray
face
health
care
worker
comment
docket
includ
data
fluid
resist
properti
nonfda
clear
ffr
manufactur
evalu
fluid
resist
sm
surgic
ffr
accord
astm
method
method
also
use
test
fluid
resist
respir
research
purpos
fluid
resist
test
qualit
method
base
visual
inspect
resist
synthet
blood
penetr
test
differ
veloc
cmsec
correspond
rang
human
blood
pressur
mm
hg
respect
fda
clearanc
surgic
ffr
requir
test
sampl
model
sampl
must
pass
astm
fluid
resist
test
veloc
fda
clear
surgic
ffr
level
fluid
resist
base
perform
differ
veloc
fluid
resist
low
medium
high
level
refer
devic
pass
test
cm
sec
veloc
respect
level
fluid
resist
directli
relat
test
veloc
model
may
pass
test
cmsec
wherea
other
may
also
pass
cmsec
even
cmsec
model
pass
test
highest
veloc
would
higher
level
resist
compar
model
pass
test
lower
veloc
cmsec
studi
nioshapprov
ffr
commonli
use
industri
workplac
evalu
fluid
resist
ffr
manufactur
test
resist
synthet
blood
penetr
use
astm
standard
method
niosh
morgantown
wv
result
compar
obtain
thirdparti
independ
tpi
laboratori
nelson
laboratori
salt
lake
citi
utah
parallel
resist
test
done
fdaclear
surgic
ffr
sm
categori
devic
passfail
result
ffr
surgic
ffr
sm
cmsec
veloc
evalu
consist
test
method
assess
compar
result
obtain
niosh
laboratori
result
tpi
laboratori
result
limit
test
method
futur
need
discuss
six
ffr
model
surgic
ffr
model
sm
model
select
studi
two
surgic
model
chosen
ident
physic
appear
nonfda
clear
model
wherea
other
select
randomli
lead
manufactur
base
upon
market
share
strateg
nation
stockpil
manufactur
devic
synthet
blood
penetr
test
apparatu
blood
spurt
tester
model
sdl
atla
llc
rock
hill
sc
similar
describ
astm
standard
use
studi
test
apparatu
consist
specimenhold
fixtur
target
plate
pressur
fluid
reservoir
pneumat
actuat
valv
interchang
canula
stainless
steel
intern
diamet
cm
valv
control
canula
size
suitabl
test
synthet
blood
penetr
arteri
blood
pressur
rang
mm
hg
correspond
cmsec
veloc
specimen
holder
support
frame
fixtur
rigid
resist
impact
bloodspray
process
height
specimen
holder
mm
correspond
height
synthet
blood
reservoir
target
plate
hole
place
cm
front
mask
ensur
synthet
blood
hit
target
area
mask
actuat
valv
attach
stabl
metal
stand
withstand
flex
activ
pneumat
control
valv
posit
accord
astm
method
exit
canula
cm
point
impact
specimen
mask
fluid
reservoir
fill
approxim
l
fresh
synthet
blood
johnson
moen
co
inc
rochest
minn
canula
instal
front
pneumat
control
valv
canula
use
method
long
stainless
needl
intern
diamet
cm
synthet
blood
penetr
test
perform
veloc
cmsec
correspond
blood
pressur
mm
hg
respect
reservoir
pressur
adjust
approxim
psi
psi
achiev
veloc
cmsec
cmsec
respect
test
apparatu
calibr
target
veloc
deliv
synthet
blood
differ
spurt
durat
weight
synthet
blood
deliv
second
second
spurt
collect
separ
small
beaker
weight
sampl
record
differ
weight
calcul
accord
astm
target
differ
weight
plu
lower
upper
limit
veloc
rang
within
target
target
differ
weight
test
target
veloc
cmsec
g
g
respect
studi
accept
weight
rang
g
g
cmsec
veloc
g
g
cmsec
veloc
within
specifi
rang
test
ml
g
synthet
blood
direct
test
sampl
durat
second
second
correspond
target
veloc
cmsec
cmsec
respect
everi
sampl
check
perform
ensur
test
apparatu
still
deliv
g
synthet
blood
collect
weigh
output
pass
target
hole
blood
sampl
deliv
show
shift
g
prior
data
sinc
last
calibr
discard
canula
also
clean
test
sampl
use
test
sampl
condit
environment
chamber
caron
environment
chamber
model
marietta
ohio
hour
temperatur
c
ae
c
ae
rel
humid
simul
temperatur
humid
condit
mask
wearer
test
sampl
remov
environment
chamber
mount
test
apparatu
center
synthet
blood
dispers
target
veloc
within
minut
synthet
blood
penetr
sampl
assess
visual
control
mask
model
categori
devic
use
comparison
drop
blood
place
inner
side
control
mask
compar
color
inner
side
test
sampl
fluid
resist
passfail
data
test
veloc
niosh
laboratori
tpi
laboratori
combin
statist
analysi
data
differ
test
veloc
laboratori
compar
wilcoxon
signedrank
test
match
pair
use
spss
softwar
version
ibmspss
inc
armonk
ny
synthet
blood
penetr
result
obtain
niosh
laboratori
compar
result
obtain
tpi
laboratori
tabl
number
sampl
test
veloc
niosh
laboratori
vari
model
wherea
sampl
per
model
test
tpi
laboratori
despit
differ
number
sampl
test
laboratori
penetr
result
obtain
niosh
compar
tpi
laboratori
exampl
ffr
model
ie
b
c
e
f
show
penetr
niosh
laboratori
also
penetr
tpi
laboratori
model
show
penetr
sampl
test
veloc
laboratori
similarli
sampl
model
show
penetr
cmsec
test
laboratori
penetr
obtain
surgic
ffr
model
ie
h
cmsec
test
laboratori
case
sm
model
show
penetr
veloc
niosh
laboratori
penetr
tpi
laboratori
model
penetr
cmsec
niosh
laboratori
veloc
tpi
laboratori
overal
test
result
laboratori
although
niosh
laboratori
found
sampl
ie
higher
failur
rate
tpi
laboratori
ie
differ
statist
signific
p
fda
clearanc
synthet
blood
penetr
sampl
devic
evalu
use
astm
standard
test
method
achiev
accept
qualiti
limit
defin
american
nation
standard
instituteamerican
societi
qualiti
control
standard
accept
qualiti
limit
includ
minor
deviat
standard
accept
synthet
blood
penetr
sampl
pass
test
sampl
show
penetr
cmsec
lowest
test
veloc
minimum
devic
pass
test
cmsec
indic
lower
fluid
resist
level
high
fluid
resist
devic
pass
penetr
test
veloc
tabl
show
blood
penetr
result
total
number
sampl
model
test
studi
result
niosh
tpi
laboratori
sampl
combin
limit
number
sampl
test
laboratori
moreov
similar
trend
penetr
obtain
laboratori
sampl
model
nioshapprov
ffr
show
penetr
ffr
model
model
penetr
sampl
cmsec
sampl
cmsec
indic
model
may
pass
resist
test
cmsec
cmsec
model
show
penetr
sever
sampl
lower
veloc
laboratori
see
tabl
contradictori
result
obtain
lowest
veloc
whether
model
meet
fluid
resist
requir
uncertain
three
surgic
ffr
model
test
studi
model
h
failur
either
veloc
sampl
model
g
pass
test
cmsec
wherea
model
sampl
fail
test
cmsec
two
sm
model
test
sampl
model
fail
lowest
veloc
initi
studi
test
full
recommend
sampl
size
possibl
say
certainti
whether
ffr
model
failur
would
meet
fda
clearanc
requir
howev
four
model
failur
even
highest
veloc
first
sampl
would
seem
like
would
pass
test
continu
recommend
sampl
size
surgic
ffr
model
h
specif
includ
studi
appear
ident
nonfda
clear
ffr
model
ie
c
e
model
c
flatfold
respir
manufactur
visual
appear
ident
except
color
orang
white
similarli
e
h
ident
appear
except
label
packag
shown
tabl
pair
exhibit
similar
fluid
resist
properti
overal
result
show
increas
synthet
blood
penetr
increas
test
veloc
fig
similar
studi
comparison
veloc
passfail
data
obtain
test
laboratori
combin
number
sampl
categori
mask
show
penetr
increas
increas
veloc
cmsec
ffr
surgic
sm
mask
show
penetr
sampl
cmsec
increas
sampl
cmsec
percentag
sampl
show
penetr
significantli
p
higher
cmsec
cmsec
penetr
larg
number
sampl
higher
veloc
expect
increas
test
veloc
like
increas
permeabl
mask
fluid
includ
synthet
blood
factor
includ
configur
differ
type
filter
media
use
multilay
construct
mask
gener
hydrophob
filter
mediacontain
model
less
like
show
penetr
abil
retard
penetr
hydrophil
challeng
test
agent
presenc
hydrophob
filter
media
outer
surfac
may
provid
barrier
entri
hydrophil
waterbas
synthet
blood
lack
penetr
devic
may
maintain
outer
surfac
hydrophob
dri
penetr
expect
outer
layer
wet
gain
inform
synthet
blood
resist
mask
penetr
differ
layer
mask
analyz
visual
model
block
initi
spray
differ
found
synthet
blood
move
layer
devic
figur
show
blood
penetr
differ
layer
respir
model
repres
ffr
sampl
model
c
model
pass
resist
test
analyz
blood
penetr
differ
layer
blood
color
seen
outer
inner
side
outer
layer
model
c
respect
middl
layer
model
c
respect
red
color
outer
inner
side
model
c
respect
innermost
layer
mask
demonstr
blood
penetr
two
ffr
model
fail
test
shown
blood
color
inner
side
mask
model
layer
filter
media
outer
inner
side
model
outermost
layer
show
wide
area
synthet
blood
color
middl
layer
rel
smaller
area
color
outer
surfac
model
diminish
inner
side
model
indic
littl
blood
penetr
surprisingli
larger
area
blood
color
seen
outer
surfac
innermost
layer
model
increas
along
creas
line
inner
side
model
expos
face
result
consist
differ
sampl
model
result
support
design
respir
differ
layer
filter
media
outer
layer
thin
hydrophob
blood
abl
penetr
veloc
test
studi
dens
middl
hydrophob
layer
separ
layer
consid
singl
layer
simplic
although
hydrophob
middl
layer
appear
decreas
blood
penetr
dramat
shown
reduct
area
blood
color
actual
allow
blood
pass
seen
appear
wide
area
blood
color
innermost
hydrophil
layer
affin
toward
waterbas
synthet
blood
case
model
ffr
b
ffr
c
ffr
ffr
e
ffr
f
surgic
ffr
g
test
veloc
cmsec
outer
shell
hydrophob
layer
second
shell
layer
fig
bottom
panel
hydrophob
layer
suffici
prevent
blood
penetr
test
veloc
result
indic
number
hydrophil
hydrophob
filter
media
pack
densiti
layer
arrang
layer
outer
inner
side
mask
may
influenc
blood
penetr
penetr
synthet
blood
hydrophob
filter
media
layer
rais
question
interpret
test
method
case
model
inner
side
middl
hydrophob
layer
show
trace
blood
color
howev
blood
penetr
middl
layer
could
seen
wide
area
color
outer
inner
side
innermost
hydrophil
layer
indic
innermost
layer
made
hydrophil
materi
reveal
penetr
synthet
blood
absenc
hydrophil
layer
devic
may
still
allow
blood
penetr
may
easili
identifi
test
method
result
indic
need
develop
accur
test
method
identifi
blood
penetr
inner
side
mask
either
hydrophil
hydrophob
layer
synthet
blood
penetr
test
address
potenti
infecti
biolog
fluid
reachingtouch
human
face
surgic
environ
scenario
splashesspray
occur
outsid
surgic
procedur
exampl
signific
volum
respiratori
secret
infect
individu
releas
high
veloc
form
sneez
cough
spray
splash
nearbi
individu
wear
sm
ffr
possibl
devic
may
allow
penetr
biolog
fluid
exist
wide
variat
construct
design
mani
surgic
ffr
ffr
prevent
inner
surfac
respir
touch
user
face
hand
model
flatfold
type
respir
may
touch
facial
skin
breath
indic
nasal
secret
diffus
mask
high
humid
condit
mask
one
studi
test
human
subject
wear
sm
evalu
physiolog
thermal
subject
influenc
sm
wearer
author
report
subject
complain
sm
stick
face
inhal
studi
need
understand
diffus
biolog
fluid
filter
media
sm
surgic
respir
ffr
result
synthet
blood
penetr
test
obtain
studi
may
implic
respir
use
health
care
environ
fda
clear
small
percentag
nioshapprov
ffr
surgic
respir
extens
use
surgic
ffr
surgic
nonsurg
health
care
practic
result
shortag
emerg
pandem
event
involv
respiratori
pathogen
address
issu
niosh
could
incorpor
addit
test
requir
cfr
part
respir
approv
process
parallel
protect
fda
clearanc
surgic
respir
current
fda
clearanc
procedur
accept
niosh
respir
certif
lieu
filter
effici
perform
differenti
pressur
theori
similar
arrang
streamlin
approv
could
made
niosh
began
evalu
fluid
resist
part
certif
process
studi
show
ffr
model
approv
niosh
clear
fda
like
also
meet
fluid
resist
requir
surgic
ffr
clearanc
even
ffr
model
demonstr
lesser
fluid
resist
abil
still
pass
rate
lowest
veloc
insuffici
meet
requir
standard
suggest
abil
provid
level
fluid
resist
detail
analysi
pro
con
niosh
incorpor
fluid
resist
requir
cfr
part
respir
approv
influenc
infect
control
polici
respir
shortag
outsid
scope
articl
need
abil
ffr
test
pass
greater
lowest
veloc
also
present
opportun
scrutin
need
specif
test
determin
suitabl
respir
use
medic
environ
situat
increas
respir
use
like
pandem
need
protect
projectil
blood
cmsec
may
less
common
need
protect
lowerveloc
splashesspray
cough
sneez
talk
addit
studi
need
determin
whether
nonfda
clear
ffr
would
suffici
type
situat
preliminari
data
promis
limit
studi
includ
nonfda
clear
nioshapprov
ffr
model
test
synthet
blood
penetr
addit
model
need
test
provid
conclus
inform
whether
ffr
model
would
meet
exist
fda
requir
penetr
resist
synthet
blood
astm
standard
test
method
requir
sampl
per
model
obtain
accept
qualiti
limit
mean
sampl
pass
test
studi
sampl
per
model
laboratori
test
synthet
blood
penetr
futur
studi
use
sampl
per
model
describ
astm
standard
test
method
limit
includ
subject
natur
blood
penetr
test
well
variat
test
result
obtain
differ
test
perform
laboratori
well
laboratori
nevertheless
synthet
blood
penetr
result
obtain
studi
indic
mani
nioshapprov
ffr
may
meet
fda
clearanc
requir
synthet
blood
penetr
although
mani
model
would
like
pass
synthet
blood
penetr
criterion
whether
would
pass
flammabl
test
fda
clearanc
remain
evalu
studi
blood
penetr
longer
time
may
provid
inform
chang
penetr
pattern
expos
mask
worn
protract
period
four
nioshapprov
ffr
model
clear
fda
test
studi
show
resist
synthet
blood
penetr
cmsec
veloc
similar
result
obtain
tpi
laboratori
combin
result
resist
blood
penetr
laboratori
indic
model
may
pass
fda
clearanc
process
provid
also
pass
flammabl
requir
expect
number
respir
sampl
fail
test
increas
increas
test
veloc
respir
design
use
differ
number
hydrophil
hydrophob
filter
media
layer
differ
pack
densiti
may
influenc
resist
blood
penetr
